ASLAN Pharmaceuticals Limited Shares Sold by Tang Capital Management LLC
ASLNDelisted Stock | USD 0.60 0.03 4.76% |
About 62% of Aslan Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Aslan Pharmaceuticals suggests that many traders are alarmed regarding Aslan Pharmaceuticals' prospects. Aslan Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Aslan Pharmaceuticals. Many technical investors use Aslan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aslan |
Tang Capital Management LLC cut its holdings in shares of ASLAN Pharmaceuticals Limited by 5.1 percent in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 5,364,925 shares of the companys stock after selling 290,000 shares during the period. Tang Capital Management
Read at thelincolnianonline.com
Aslan Pharmaceuticals Fundamental Analysis
We analyze Aslan Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aslan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aslan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Aslan Pharmaceuticals is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Aslan Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aslan Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Aslan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aslan Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Aslan Pharmaceuticals Related Equities
NAMS | NewAmsterdam Pharma | 41.41 | ||||
ACRV | Acrivon Therapeutics, | 8.45 | ||||
CMPX | Compass Therapeutics | 7.88 | ||||
LYRA | Lyra Therapeutics | 5.00 | ||||
ANTX | AN2 Therapeutics | 2.65 | ||||
ANEB | Anebulo Pharmaceuticals | 0.64 | ||||
CGEM | Cullinan Oncology | 0.24 | ||||
IVA | Inventiva | 0.38 | ||||
ERAS | Erasca | 0.67 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
GPCR | Structure Therapeutics | 1.30 | ||||
MLYS | Mineralys Therapeutics, | 1.45 | ||||
CTMX | CytomX Therapeutics | 2.48 | ||||
ACHL | Achilles Therapeutics | 2.86 | ||||
IOBT | IO Biotech | 4.55 | ||||
AGIO | Agios Pharm | 5.76 | ||||
ASMB | Assembly Biosciences | 6.46 | ||||
TIL | Instil Bio | 7.12 | ||||
GLUE | Monte Rosa | 9.85 | ||||
ADAG | Adagene | 16.21 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Global Correlations Find global opportunities by holding instruments from different markets |